title: The Australian and New Zealand Intensive Care Society Clinical Trials Group point prevalence program, 2009-2016.
abstract: BACKGROUND
  Cross-sectional point prevalence studies collect observational data at a single time point and may be used to facilitate subsequent research hypotheses and discovery.
  
  
  METHODS
  We report the process of implementation and substantive outputs of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) point prevalence program, conducted in participating intensive care units from 2009 to 2016.
  
  
  RESULTS
  Seventy-seven of a maximum 197 adult ICUs across Australia and New Zealand participated in 9 specified study days over 18 days of data collection and collected data on 5043 participants, with an average of 44 ICUs per study day. All eight Australian and New Zealand paediatric ICUs have participated in dedicated simultaneous paediatric study days. Thirteen manuscripts were published in peer-reviewed journals and data have contributed to 14 individual programs of research, including 18 subsequent grant applications for further research.
  
  
  CONCLUSIONS
  The ANZICS CTG point prevalence program has resulted in the collection of a substantial body of observational data that has facilitated the development and completion of subsequent research programs and provided opportunities for subsequent capacity development.
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Kelly
authors.initials: K
authors.lastname: Thompson
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Naomi
authors.initials: N
authors.lastname: Hammond
authors.affiliation: Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
authors.forename: Glenn
authors.initials: G
authors.lastname: Eastwood
authors.affiliation: ANZICS Clinical Trials Group, Melbourne, VIC, Australia.
authors.forename: Marino
authors.initials: M
authors.lastname: Festa
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Parisa
authors.initials: P
authors.lastname: Glass
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Dorrilyn
authors.initials: D
authors.lastname: Rajbhandari
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Ian
authors.initials: I
authors.lastname: Seppelt
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Colman
authors.initials: C
authors.lastname: Taylor
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: Nicola
authors.initials: N
authors.lastname: Watts
authors.affiliation: Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
authors.forename: John
authors.initials: J
authors.lastname: Myburgh
mesh_terms: D000328:Adult; D001315:Australia; D002648:Child; D002986:Clinical Trials as Topic; D003422:Critical Care; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D009520:New Zealand; D015995:Prevalence; D013997:Time Factors